Search clinical trials for: KRAS, HRAS, or NRAS Mutations

Total 206052 results

Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Eli Lilly and Company

Completed

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Neoplasm Metastasis

Russian Federation
Eli Lilly and Company

Completed

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Neoplasms

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

United States, Lithuania, Puerto Rico, Romania, Russian Federation
Eli Lilly and Company

Completed

Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

Argentina, Brazil, Chile, Mexico
University of Mississippi Medical Center
Kyowa Hakko Kogyo Co., Ltd.

Completed

Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Eli Lilly and Company

Completed

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

Depressive Disorder, Major

Belgium, Germany, France, Slovakia, Czech Republic, Finland
Eli Lilly and Company

Completed

A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)

Sepsis

Germany
Eli Lilly and Company

Completed

A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
Eli Lilly and Company

Completed

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Adenocarcinoma

Canada
Eli Lilly and Company

Completed

A Study in People With Abnormal Fat Levels in the Blood

Dyslipidemia

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company
Aventis Pharmaceuticals

Completed

A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Italy
Eli Lilly and Company

Completed

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Weight Gain

Italy
Eli Lilly and Company

Completed

Efficacy Study of LY2422347 to Treat Insomnia

Sleep Initiation and Maintenance Disorders

United States
Eli Lilly and Company

Completed

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Attention-Deficit/Hyperactivity Disorder | Comorbid Dyslexia

United States
Eli Lilly and Company

Completed

Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients

Osteoporosis

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States
Eli Lilly and Company

Completed

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Superficial Bladder Cancer

Italy
Eli Lilly and Company

Completed

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Shaare Zedek Medical Center

Unknown

PAR Family Polymorphisms and Placental Invasion Disorders

Miscarriage, Recurrent | Premature Labor
Eli Lilly and Company

Completed

Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes

Attention-Deficit/Hyperactivity Disorder

Canada
Eli Lilly and Company

Completed

Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials

Major Depressive Disorder

Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Stress Urinary Incontinence

United States
QDose Limited

Unknown

Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

Diabetes Mellitus

United States
Hadassah Medical Organization

Unknown

Microbial Surveillance in Children Hospitalized for Cardiovascular Surgery

Cardiac Surgery | Perioperative Prophylaxis

Israel
Geha Mental Health Center

Unknown

Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study

Depression

Israel
University of Pittsburgh

Completed

Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation

Abortion, Induced

United States
National Center for Complementary and Integrative...

Completed

Shamanic Healing for Women With Temporomandibular Joint Disorders (TMDs)

Temporomandibular Disorders

United States
Sheba Medical Center

Withdrawn

Simulation Training as a Tool for Teamwork Improvement in Multidisciplinary Intensive Care Team

Education, Health

Israel
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women

Menopause, Premature | Hysterectomy | Attitude | Perception | Ovariectomy | Estrogen Replacement Therapy

Taiwan
Sunnybrook Health Sciences Centre
Ontario Lung Association

Unknown

Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP)

Premature Birth | Respiratory Insufficiency

Canada
Sheba Medical Center

Unknown

Early Movements as a Predictor of Future Developmental Delay

Cerebral Palsy | Premature Birth

Israel
China Medical University Hospital

Unknown

Effect of Electroacupuncture in Diabetic Patients With Gastroparesis

Diabetes Mellitus | Gastroparesis

Taiwan
National Center for Complementary and Integrative...

Completed

Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System

Vestibular Neuronitis | Vestibulopathy

United States
Shanghai Jiao Tong University School of Medicine
National Institutes of Health (NIH)

Completed

Therapeutic Effects of Berberine in Patients With Type 2 Diabetes

Type 2 Diabetes

China
ID Biomedical Corporation, Quebec

Completed

Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

Influenza

United States
BZL Biologics

Completed

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Prostatic Neoplasms

United States
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients

Memory Disorders | Delirium, Dementia, Amnestic, Cognitive Disorders

Netherlands
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...

Unknown

Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer

Breast Cancer | Post-Menopausal

United States
Eyetech Pharmaceuticals
Pfizer

Completed

Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)

Retinal Vein Occlusion

United States
Wayne State University
GlaxoSmithKline

Unknown

Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication

ICU Patients 18 Years or Older.

United States
Instituto Nacional de Cardiologia Ignacio Chavez

Unknown

Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy

Acute Kidney Failure

Mexico
Pfizer

Terminated

Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease

Parkinson Disease

Colombia, United States, Argentina, Puerto Rico

Search clinical trials for: KRAS, HRAS, or NRAS Mutations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations